As a result of CCSG strategic planning and evaluation of services offered, the former Clinical Data Network (CDN) was renamed the Biomedical Data Science Shared Resource (BDS). The mission of the BDS is to contribute towards improving understanding of cancer biology and enable development of innovative preventive and therapeutic approaches for cancer. The shared resource has enhanced its service platform to better provide investigators with the infrastructure, tools, standards and technical collaboration required for cutting edge data intensive cancer research, while expanding the breadth of the resource to include development of Roswell Park-wide data standards, reusable software (database and web) tools for more complex data management needs. BDS provides high quality data science support for basic, translational and clinical research projects and assists investigators in the preparation of reliable data for funding applications and publications. BDS is integrated into the Roswell Data Science initiative, creating a robust cancer research data ecosystem populated with findable, accessible, interoperable and reusable data in the Roswell Data Commons. This shared resource has served 5 research programs and 150 Roswell Park users. BDS usage resulted in 101 peer-reviewed publications and has serviced 16 NIH grants. Roswell's bold Data Science initiative is poised to transform research and the size and quality of the data ecosystem, freeing researchers for scientific investigation and discovery. BDS works with CCSG researchers to understand scientific questions, data needs and system requirements, the BDS, in collaboration with Roswell IT, researches and recommends appropriate software for meeting the needs. BDS will be integral to the evolution of sophisticated data science capabilities and a Findable, Accessible, Interoperable, Reusable (FAIR) data ecosystem. BDS ensures that the informatics design and data model in grant applications appropriately support the analytic plan.
The specific aims of the BDS are: 1) To provide CCSG investigators with cutting-edge data science infrastructure, tools and methods to facilitate data capture and analyses; 2) To harmonize and integrate data and metadata across Roswell (including laboratory, shared resource and the clinical record) to enable basic science and clinical investigators access to data; 3) To provide expert consultation and support to address the data science needs of CCSG members, including effective data capture, management and sharing plans. With its expanded structure, BDS will be integral to the evolution of sophisticated data science capabilities. In the future, BDS will Drive the development of Roswell's cancer ontology as well as developing data standards (including Common Data Elements) for use institution-wide and supporting data interoperability, reuse and sharing.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-43
Application #
9923566
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
43
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Tubbs, Anthony; Sridharan, Sriram; van Wietmarschen, Niek et al. (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell 174:1127-1142.e19

Showing the most recent 10 out of 1555 publications